Vascular Health: Thinking Out of the Box
In this course, methods to prevent and treat CVD based on translational cardiovascular medicine are explored to get beyond the traditional approaches that only focus on the top five risk factors.
Mark Houston, MD, MS, MSc
Board Review Series
AIHM 2016 Annual Conference
Time to Complete
What you will learn
We have reached a limit in our ability to reduce the incidence of coronary heart disease (CHD) and cardiovascular disease (CVD) utilizing the traditional evaluation, prevention, and treatment strategies for the top 5 cardiovascular risk factors – hypertension, diabetes mellitus, dyslipidemia, obesity and smoking.. Statistics show that approximately 50% of patients continue to have CHD or myocardial infarction (MI) despite “normal” levels of these five risk factors as traditionally defined. A better understanding is required of the details behind these top five risk factors such as evaluation of 24 hour ambulatory blood pressure monitoring, advanced lipid profiles, dysglycemia parameters, visceral obesity, effects of adipokines and of the three finite vascular endothelial responses (inflammation, oxidative stress and immune vascular dysfunction) to the infinite insults. Understanding translational cardiovascular medicine to correlate the CHD risk factors to the presence or absence of vascular injury and disease with non ‐invasive vascular testing will allow for early identification, prevention and treatment of CHD and CVD. Cardiovascular medicine is in dire need of resuscitation. The heart and the vascular system are literarily on fire and our present techniques are not effective in reducing this inflammation. CVD remains the number one cause of morbidity and mortality in the United States . Statistics show that we spend over $80 billion a year treating CVD alone . More shocking is the fact that a staggering 2200 US citizens die from stroke or MI each and every day. We continue to have cholesterol‐centric approach to the management of CHD while not addressing the basic etiologies of CHD such as inflammation, oxidative stress and immune vascular dysfunction.. Furthermore, there are at least 395 other risk factors that physicians’ either do not know about or they are not using appropriate techniques to identify and treat them. Thus, it is imperative that we now begin to look at other methods to prevent and treat CVD.By the end of this course, learners will be able to:
- Review and discuss the pathophysiology, three finite responses of vascular disease, clinical presentation and cardiovascular relationships of coronary heart disease and CVD.
- Review, discuss, select and apply laboratory testing and new noninvasive diagnostic cardiovascular tests to identify CV disease early and select appropriate treatment.
- Review and discuss traditional, new and emerging CHD risk factors to prevent and treat CHD and CVD in clinical practice.
Certificate of Completion
Included in this course
Mark Houston, MD, MS, MSc
Dr. Mark Houston is Associate Clinical Professor of Medicine at Vanderbilt University School of Medicine, Clinical Instructor in the Department of Physical Therapy and Health Care Sciences at George Washington University (GWU), Director of the Hypertension Institute and Vascular Biology and Medical Director of the Division of Human Nutrition at Saint Thomas Hospital in Nashville, TN . He is the Chief Medical Officer for Ageless Solutions, US, Chief Medical Consultant for Bioceuticals and Chief Scientific officer for Bioceuticals, Australia and Chief Medical Consultant for Primal MD, Dubai, UAE.
The CME for this course has expired, however you will continue to have access to your purchased content.
This course is self-paced with no set beginning or end date. You may complete this course on your own schedule and pace. Enrolling in and purchasing this course grants you access to its contents in perpetuity.